Physician profile
Emily Grindley
NPI 1497309371
$5,386.47
in general payments reported to CMS, 2019-2025
11 companies · $2,764 in 2025
The $2,764 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $646 · 2024: $1,977 · 2025: $2,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,223 · Food and Beverage: $1,486 · Education: $31.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,222.79 |
| Food and Beverage | $1,486.20 |
| Education | $31.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,622.86 | 2024-2025 | Interstim, N'Vision |
| Boston Scientific Corporation | $1,596.36 | 2025 | Axonics |
| Thd America, INC. | $949.61 | 2025 | |
| Abbvie INC. | $541.62 | 2021-2024 | |
| Nestle Healthcare Nutrition INC. | $203.36 | 2021 | |
| Urgo Medical North America, LLC | $140.70 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Teva Pharmaceuticals USA, INC. | $116.10 | 2024 | Austedo Xr |
| Axonics, INC. | $105.90 | 2024 | Axonics |
| Takeda Pharmaceuticals U.S.A., INC. | $48.34 | 2024 | Gattex |
| Baxter Healthcare | $31.32 | 2025 | Tisseel |
| Ethicon US, LLC | $30.30 | 2025 | Echelon Circular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Grindley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.